Content

Info

Links

Welcome to the CJU website » LOG IN
online search

Results for - " Morton G"    Showing 11 Results by Author

  1. Patient costs associated with external beam radiotherapy treatment for localized prostate cancer: the benefits of hypofractionated over conventionally fractionated radiotherapy
    Sethukavalan Perakaa , Cheung Patrick , Tang I. Colin. , Quon Harvey , Morton Gerard , Nam Robert , Loblaw Andrew;
    The Canadian Journal of Urology
    Apr 2012 (Volume 19, Issue 2, Pages 6165 - 6169)
    PMID: 22512958
    Abstract  |  PDF (104.54 KB) Free
  1. How are hemoglobin levels affected by androgen deprivation in non-metastatic prostate cancer patients?
    Choo Richard, Chander Sarat, Danjoux Cyril, Morton Gerard, Pearce Andrew, Deboer Gerrit, Szumacher Ewa, Loblaw Andrew, Cheung Patrick, Woo Tony;
    The Canadian Journal of Urology
    Feb 2005 (Volume 12, Issue 1, Pages 2547 - 2552)
    Abstract  |  PDF (138.38 KB) Free
  1. Prostate cancer radiotherapy 2002: the way forward
    Lukka Himu, Pickles Tom, Morton Gerard, Catton Charles, Souhami Luis, Warde Padraig;
    The Canadian Journal of Urology
    Feb 2005 (Volume 12, Issue 1, Pages 2521 - 2531)
    Abstract  |  PDF (161.03 KB) Free
  1. Comparison of histologic grade between initial and follow-up biopsy in untreated, low to intermediate grade, localized prostate cancer
    Choo R., FRANCZCR V. Do, Sugar L., Klotz H. Laurence, Bahk E., Hong E., Danjoux C., Morton G., DeBoer G.;
    The Canadian Journal of Urology
    Feb 2004 (Volume 11, Issue 1, Pages 2118 - 2124)
    Abstract  |  PDF (61.28 KB) Free
  1. Is there a progression of histologic grade from radical prostatectomy to local recurrence in patients with clinically isolated local recurrence follow
    Choo R., Sugar L., Hong E., Mackenzie K., DeBoer G., Danjoux C., Morton G., Klotz H. LaurenceL.;
    The Canadian Journal of Urology
    Oct 2003 (Volume 10, Issue 5, Pages 1981 - 1985)
    Abstract  |  PDF (52.68 KB) Free
  1. Controversies in prostate cancer radiotherapy: consensus development
    Lukka Himu, Warde Padraig, Pickles Tom, Morton Gerard, Brundage Michael, Souhami Luis;
    The Canadian Journal of Urology
    Aug 2001 (Volume 8, Issue 4, Pages 1314 - 1322)
    Abstract  |  No PDF Available.  
  1. Should pathological T3 and/or margin positive prostate cancer receive adjuvant therapy? A radiation oncologists view
    Choo Richard C., Danjoux Cyril, Morton C. Gerard;
    The Canadian Journal of Urology
    Jun 2000 (Volume 7, Issue 3, Pages 1043 - 1050)
    Abstract  |  No PDF Available.  
  1. Long term outcome and cost in the management of stage I testicular seminoma - page 967
    Morton Gerard;
    The Canadian Journal of Urology
    Apr 2000 (Volume 7, Issue 2, Pages 973 - 973)
    Abstract  |  No PDF Available.  
  1. Pathological T3 and/or margin positive prostate adenocarcinoma with undetectable postoperative PSA - to irradiate or not?: analysis of freedom from P
    Flavin A., Choo R., Franssen E., Danjoux C., Morton G.;
    The Canadian Journal of Urology
    Jun 1998 (Volume 5, Issue 2, Pages 544 - 550)
    Abstract  |  No PDF Available.  
  1. Survey of consecutive prostate cancer patients attending the Toronto Sunnybrook Regional Cancer Centre (TSRCC)
    Danjoux E. Cyril, DeBoer G., Choo C. Richard, Iscoe A. Neil, Morton C. Gerard, Young S. Charlene, Bjarnason A. Georg, Klotz H. Laurence;
    The Canadian Journal of Urology
    Nov 1996 (Volume 3, Issue 4, Pages 268 - 276)
    Abstract  |  No PDF Available.  
  1. Changing management of localized prostate cancer: a comparison survey of Ontario radiation oncologists
    Martin Jarad, Rodrigues George, Malone Shawn, Morton Gerard, Campbell Holly, Crook Juanita;
    The Canadian Journal of Urology
    Apr 2006 (Volume 13, Pages 26 - 33)
    Abstract  |  PDF (80.77 KB) Free